The Dividend Yield as of November 2024 (TTM) for Halozyme Therapeutics, Inc. (HALO) is 0%

According to Halozyme Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of -100.00% compared to the average of 0.07% of the last 4 quarters.

Halozyme Therapeutics, Inc. (HALO) Historical Dividend Yield (quarterly & annually)

How has HALO Dividend Yield performed in the past?

The mean historical Dividend Yield of Halozyme Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), HALO's Dividend Yield was at its highest in in the December 2019 quarter at 7.43%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Halozyme Therapeutics, Inc. (HALO) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Halozyme Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Halozyme Therapeutics, Inc. (HALO) Average Dividend Yield

How has HALO Dividend Yield performed in the past?

The current Dividend Yield of Halozyme Therapeutics, Inc. (HALO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Halozyme Therapeutics, Inc. (HALO) Dividend Yield vs. Peers

How is HALO’s Dividend Yield compared to its peers?

Halozyme Therapeutics, Inc.’s Dividend Yield is less than Agios Pharmaceuticals, Inc. (0%), less than Insmed Incorporated (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Ultragenyx Pharmaceutical Inc. (0%), less than BioMarin Pharmaceutical Inc. (0%), less than Seagen Inc. (0%), less than Alnylam Pharmaceuticals, Inc. (0%), less than Exelixis, Inc. (0%), less than Alector, Inc. (0%), less than Legend Biotech Corporation (0%), less than Ascendis Pharma A/S (0%), less than Cytokinetics, Incorporated (0%), less than Edgewise Therapeutics, Inc. (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than BeiGene, Ltd. (0%), less than Inhibrx Biosciences, Inc. (5.47%), less than Protagonist Therapeutics, Inc. (0%), less than DICE Therapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Viridian Therapeutics, Inc. (0%),

Build a custom stock screener for Halozyme Therapeutics, Inc. (HALO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Halozyme Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Halozyme Therapeutics, Inc. (HALO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Halozyme Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.